Stem cell therapy in cystic fibrosis

A. Jaffe (London, United Kingdom)

Source: Annual Congress 2004 - New approaches to cystic fibrosis: from cells and molecules to novel therapies
Session: New approaches to cystic fibrosis: from cells and molecules to novel therapies
Session type: Assembly Symposium
Number: 4024

Slide presentation

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Jaffe (London, United Kingdom). Stem cell therapy in cystic fibrosis. Annual Congress 2004 - New approaches to cystic fibrosis: from cells and molecules to novel therapies

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung stem cells and therapy for cystic fibrosis
Source: Eur Respir Monogr 2021; 91: 306-321
Year: 2021


Stem cell therapy in IPF
Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside
Year: 2014



Targeting CFTR as a therapy for cystic fibrosis
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010

MiR-31 regulates IRF-1 function in cystic fibrosis epithelial cells
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014

Lung transplantation for cystic fibrosis
Source: Eur Respir Monogr 2014; 64: 236-245
Year: 2014


Lung transplantation for cystic fibrosis
Source: International Congress 2015 – Lung transplantation in the year 2015: current indications and results
Year: 2015



Epithelial cell regulation of immunity in cystic fibrosis
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research
Year: 2012

Inhalation therapy in cystic fibrosis
Source: School Course 2013 - Cystic Fibrosis
Year: 2013

Regulation of interleukin-8 by miR-17 during chronic inflammation in cystic fibrosis
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015



Antiviral activity of azithromycin in cystic fibrosis airway epithelial cells
Source: International Congress 2014 – Cystic fibrosis: assessment and treatment
Year: 2014


Alveolar type II cells transplantation decrease fibrocyte migration in pulmonary fibrosis
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013


Effect of pirfenidone on TGF-beta-induced pro-fibrotic effects in primary human lung cells derived from patients with idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 2
Year: 2014

Novel antiviral properties of vitamin D in cystic fibrosis airway epithelial cells
Source: International Congress 2014 – Cystic fibrosis: assessment and treatment
Year: 2014

Epithelial mesenchymal transition in fibroblastic foci of different fibrosing lung diseases: Repair or remodeling?
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013

New horizons for cystic fibrosis gene and cell therapy
Source: Eur Respir Monogr 2014; 64: 150-168
Year: 2014


Individual treatment of cystic fibrosis by using intestinal organoids
Source: International Congress 2015 – Advancing therapies for cystic fibrosis
Year: 2015



Pluripotent stem cells isolated from adult human lung tissue exhibit anti-fibrotic properties
Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Year: 2013